A new analysis from the Campaign for Sustainable Rx Pricing (CSRxP) demonstrates how the pharmaceutical industry’s profit margins are ten times greater than other sectors of the prescription drug supply chain.
By the numbers:
- The pharmaceutical industry’s average annual net income margin was nearly 23%.
- The average margin for other sectors of the U.S. prescription drug supply chain – including distributors, retail pharmacies, PBMs and health plans – was just 2.3%.
